All > Sle > Parkinson

Deep Brain Stimulation for Parkinson's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Parkinson's Disease+1 MoreDeep Brain Stimulation - Device
Eligibility
19 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether an adaptive stimulation protocol can improve sleep quality for adults with Parkinson's disease.

Eligible Conditions
  • Parkinson's Disease
  • Sleep Fragmentation

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

3
Pitolisant (Wakix)
1
Deep Brain Stimulation
1
Medtronic PC+S Deep Brain Stimulation

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Years 1-3

Years 1-3
Duration of REM sleep stage
Sleep efficiency
Subjective Sleep Quality

Trial Safety

Safety Progress

1 of 3

Similar Trials

3
Pitolisant (Wakix)
1
Deep Brain Stimulation
1
Medtronic PC+S Deep Brain Stimulation

Side Effects for

Deep Brain Stimulation
23%Fall
15%Depression
8%Restless legs syndrome
8%Apathy
8%Hand fracture
5%Urinary tract infection
5%Speech disorder
5%Influenza
5%Head injury
5%Dystonia
5%Tremor
5%Gait disturbance
5%Skeletal injury
5%Paraesthesia
5%Back pain
5%Dyspepsia
3%Rapid eye movements sleep abnormal
3%Ingrowing nail
3%Hallucination, auditory
3%Impulse-control disorder
3%Insomnia
3%Panic attack
3%Confusional state
3%Depressed mood
3%Implant site infection
3%Localised infection
3%Staphylococcal infection
3%Device migration
3%Joint sprain
3%Skin laceration
3%Parkinson's disease
3%Syncope
3%Fibula fracture
3%Rib fracture
3%Memory impairment
3%Movement disorder
3%Nerve root lesion
3%Sciatica
3%Bronchitis
3%Ear infection
3%Incision site infection
3%Bursitis
3%Intervertebral disc protrusion
3%Neck pain
3%Pain in extremity
3%Spinal osteoarthritis
3%Adverse drug reaction
3%Axillary pain
3%Drug withdrawal syndrome
3%Implant site haematoma
3%Oedema peripheral
3%Productive cough
3%Diabetes mellitus
3%Fluid retention
3%Folate deficiency
3%Macular degeneration
3%Laboratory test abnormal
3%Pericardial effusion
3%Seborrhoeic keratosis
3%Urinary incontinence
3%Respiratory depression
3%Anxiety
3%Cyst
3%Hypertension
3%Hypotension
3%Pneumonia
3%Cystitis
3%Akinesia
3%Helicobacter gastritis
3%Alcohol poisoning
3%Thermal burn
3%Cerebral microangiopathy
3%Hypoaesthesia
3%Contusion
3%Dysarthria
3%Anger
3%Postoperative wound infection
3%Arthralgia
3%Cough
3%Pleural effusion
3%Monarthritis
3%Osteoarthritis
3%Diplopia
3%Pyrexia
3%Weight increased
3%Thrombophlebitis
This histogram enumerates side effects from a completed 2018 Phase 2 trial (NCT01221948) in the Deep Brain Stimulation ARM group. Side effects include: Fall with 23%, Depression with 15%, Restless legs syndrome with 8%, Apathy with 8%, Hand fracture with 8%.

Trial Design

3 Treatment Groups

No DBS Stimulation
1 of 3
Open-loop DBS stimulation
1 of 3
Adaptive DBS stimulation
1 of 3

Active Control

Experimental Treatment

20 Total Participants · 3 Treatment Groups

Primary Treatment: Deep Brain Stimulation · No Placebo Group · N/A

Adaptive DBS stimulation
Device
Experimental Group · 1 Intervention: Deep Brain Stimulation · Intervention Types: Device
No DBS StimulationNoIntervention Group · 1 Intervention: No DBS Stimulation · Intervention Types:
Open-loop DBS stimulation
Device
ActiveComparator Group · 1 Intervention: Deep Brain Stimulation · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deep Brain Stimulation
2011
Completed Phase 2
~700

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: years 1-3

Who is running the clinical trial?

University of NebraskaLead Sponsor
487 Previous Clinical Trials
1,149,330 Total Patients Enrolled
Aviva Abosch, MD, PhDPrincipal InvestigatorUniversity of Nebraska
3 Previous Clinical Trials
91 Total Patients Enrolled

Eligibility Criteria

Age 19 - 80 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have motor symptoms that have been present for at least 4 years.
Patient has requested DBS surgery, and has been approved by the site (UNMC or University of Pennsylvania) Multi-Disciplinary Movement Disorders Patient Care Conference for STN DBS.
You are a female and are between the ages of 18 and 80 years.
Absence of abnormalities on brain MRI suggestive of an alternate diagnosis or serving as a contraindication to surgery.
You have no significant cognitive deficits or significant depression (BDI-II score > 20) on formal Neuropsychological Testing.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top